Page | |
EDITORIALS |
796 | Recommendations from The Medical Education Editor
|
799 | Vaccination in patients with COPD: COVID has raised the bar
|
801 | Rheumatoid factor and anti-citrullinated antibodies in non-connective tissue interstitial lung disease: The chicken or the egg?
|
804 | Another line of defence
|
806 | Breathlessness: Remembering the worst of it
Anne E Holland BAppSc(Physio), PhD, Janet Bondarenko BPhty, PostGradDip(Public Health)
10.1111/resp.14329
See related article |
808 | Endotyping in sleep surgery: Not ready for primetime
|
COMMENTARIES |
810 | World Lung Day 2022—Lung health for all
|
812 | Sleep medicine is more than just obstructive sleep apnoea
|
INVITED REVIEW SERIES |
Emerging Innovations, Interventions and Directions in Thoracic Imaging |
815 | Transformative radiology: Chest imaging is being re-defined
|
818 | Innovations in thoracic imaging: CT, radiomics, AI and x-ray velocimetry
|
INVITED REVIEW |
834 | Bayesian adaptive clinical trial designs for respiratory medicine
|
ORIGINAL ARTICLES |
COPD |
844 |
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations
Yan Li, Pingshu Zhang, Zhijie An, Chenyan Yue, Yamin Wang, Yunqiu Liu, Xiaodong Yuan, Ying Ma, Keli Li, Zundong Yin, Liye Wang, Huaqing Wang
10.1111/resp.14309
We studied the effectiveness of trivalent seasonal influenza vaccine (TIV) and 23-valent pneumococcal polysaccharide vaccine (PPSV23), separately and combined, at preventing acute exacerbations of chronic obstructive pulmonary disease (COPD), pneumonia and related hospitalization. TIV and PPSV23 vaccine combined appeared to reduce the incidence of adverse COPD outcomes most effectively. Separately or together, their effectiveness for preventing AECOPD was the greatest. On their own, TIV seemed more effective than PPSV23.
See related Editorial |
Interstitial Lung Disease |
854 | Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease
Boyang Zheng, Kathryn Donohoe, Nathan Hambly, Kerri A Johannson, Deborah Assayag, Jolene H Fisher, Helene Manganas, Veronica Marcoux, Nasreen Khalil, Martin Kolb, Christopher J Ryerson, on behalf of the CARE-PF Investigators
10.1111/resp.14301
We show that rheumatoid factor and anti-citrullinated peptide antibody are not associated with outcomes or response to immunosuppression in patients with interstitial lung diseases not due to connective tissue disease, indicating the need for future studies to test the prognostic impact of other clinical and radiological features that may predict response to therapy.
See related Editorial |
Interventional Pulmonology |
863 | Prevention of droplet dispersal with ‘e-mask’: A new daily use endoscopic mask during bronchoscopy
Takayasu Ito, Shotaro Okachi, Kazuhide Sato, Hirotoshi Yasui, Noriaki Fukatsu, Masahiko Ando, Toyofumi Fengshi Chen-Yoshikawa, Hideo Saka
10.1111/resp.14321
A new type of endoscopic mask (e-mask) reduced the number and volume of dispersed airborne particles during bronchoscopy. No significant differences in adverse events or complications during bronchoscopy were observed between the use of the e-mask and a patient wearing no mask, supporting its enhanced protection and safety during bronchoscopy.
See related Editorial |
Lung Function |
874 | Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology
Jacob Sandberg, Josefin Sundh, Peter Anderberg, David C Currow, Miriam Johnson, Robert Lansing, Magnus Ekström
10.1111/resp.14313
Recall of breathlessness is essential for clinical care but might differ from the momentary symptoms. This study reports that the peak momentary breathlessness most strongly influences recalled breathlessness over the past 7 days. Recall for 1 day was influenced the most by the mean breathlessness value for that day.
See related Editorial |
Pleural Disease |
882 | Ipsilateral and contralateral hemidiaphragm dynamics in symptomatic pleural effusion: The 2nd PLeural Effusion And Symptom Evaluation (PLEASE-2) Study
Deirdre B Fitzgerald, Sanjeevan Muruganandan, Carolyn J Peddle-McIntyre, Y C Gary Lee, Bhajan Singh
10.1111/resp.14307
This is the first study to show that symptomatic pleural effusion is associated with compensatory contralateral hemidiaphragm hyperactivity. Breathlessness improvement post-drainage is associated with improved ipsilateral hemidiaphragm dynamics and normalization of contralateral activity. |
Sleep and Ventilation |
890 | Examining the impact of multilevel upper airway surgery on the obstructive sleep apnoea endotypes and their utility in predicting surgical outcomes
Ai-Ming Wong, Shane A Landry, Simon A Joosten, Luke D J Thomson, Anthony Turton, Jeremy Stonehouse, Darren R Mansfield, Glen Burgess, Andrew Hays, Scott A Sands, Christopher Andara, Caroline J Beatty, Garun S Hamilton, Bradley A Edwards
10.1111/resp.14280
This is the first study to measure how upper airway surgery affects all four obstructive sleep apnoea (OSA) endotypes using both the continuous positive airway pressure dial-down and clinical polysomnographic methods. Using either method, surgery unpredictably altered the upper airway anatomy/collapsibility and did not alter the non-anatomical endotypes. None of the baseline OSA endotypes were able to predict the response to surgery.
See related Editorial |
LETTERS FROM ASIA-PACIFIC AND BEYOND |
900 |
Leading women in respiratory medicine: The role of the APSR in promoting gender equity and inclusiveness
Fanny Wai San Ko MD, Natasha Smallwood BMedSci, MBBS, SpecCertPallCare, MSc (Epid), FRCP, FRACP, PhD
10.1111/resp.14342
Special Series: Leading Women in Respiratory Medicine
Series Editors: Natasha Smallwood and Fanny Wai San Ko
See related editorial |
903 | Letter from Austria
|
CORRIGENDUM |
905 | Corrigendum
10.1111/resp.14356
This article corrects the following:
Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF
Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J Butte, Harold R Collard
10.1111/resp.13753 |